An interventional study of Telemonitoring in Telemonitoring in Coronary Artery Disease, sponsored by Hasselt University. Completed. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-06-01.
Sponsored by Hasselt University · Not applicable, Interventional, and Treatment
TEMA-HF 1 Long-Term Follow-up study is a follow-up study of TEMA-HF 1. It assessed the long-term impact of a 6-months telemonitoring program in chronic heart failure patients.
The telemonitoring (TM) group patients received a 6-months TM program, followed by standard heart failure care until the long-term follow-up evaluation.
The usual care (UC) patients received ususal care during the first six months, followed by standard heart failure care until the long-term follow-up evaluation.
5,701 studies on the registry are indexed under Heart Failure; 1,220 are open to participants now.
This study's enrollment of 160 is above the median of 72 across 3,736 interventional studies indexed under Heart Failure.
Browse Heart Failure studies →Hasselt University is the lead sponsor of 195 studies on the registry; 30 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
6 months of telemonitoring (t0-t1), followed by usual care up until common long-term stopping date (t1-t2).
Other: Telemonitoring
Usual care from t0 up until the common stopping date (t2).
All-cause mortality
All-cause mortality
Time frame: Start of study to long-term follow-up (6.5 years).
days lost due to heart failure readmissions
days lost due to heart failure readmissions
Time frame: Start of study to long-term follow-up (6.5 years).
days lost due to all readmissions
days lost due to all readmissions
Time frame: Start of study to long-term follow-up (6.5 years).
days lost due to death or heart failure readmissions
days lost due to death or heart failure readmissions
Time frame: Start of study to long-term follow-up (6.5 years).
percentage of follow-up time spent in hospital for heart failure
percentage of follow-up time spent in hospital for heart failure
Time frame: Start of study to long-term follow-up (6.5 years).
percentage of follow-up time spent in hospital for all reasons
percentage of follow-up time spent in hospital for all reasons
Time frame: Start of study to long-term follow-up (6.5 years).
percentage of follow-up time lost to death or heart failure readmissions
percentage of follow-up time lost to death or heart failure readmissions
Time frame: Start of study to long-term follow-up (6.5 years).
No study locations are listed for this record.
Plan to share: No
This study is completed, as verified in May 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hasselt University